<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04998227</url>
  </required_header>
  <id_info>
    <org_study_id>202103008RINB</org_study_id>
    <nct_id>NCT04998227</nct_id>
  </id_info>
  <brief_title>Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction</brief_title>
  <official_title>Latent TGF-β-binding Proteins Affect the Fibrotic Process in Renal Impairment and Cardiac Dysfunction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The project is planed to explore the impact of LTBP4 and other matrix protein and potentially&#xD;
      related biomarkers on renal outcomes, cardiac outcomes and all-cause mortality in patients&#xD;
      with suspected acute coronary syndrome (ACS).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will collect the blood samples from patients with suspect ACS. LTBP4 will&#xD;
      be the first matrix protein that are going to understand. Upon hospital arrival, blood&#xD;
      samples around 8 ml will be collected and the 2nd collection will be two weeks to one month&#xD;
      after the event. The third collection will be one year later. In the between, if any ACS&#xD;
      event develop, blood samples will be collected as protocols.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 26, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2025</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change of renal functions</measure>
    <time_frame>One month, Six month and one year</time_frame>
    <description>The investigators will follow up Cr and eGFR levels correlate with LTBP4 levels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of hospitalization</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of required myocardial revascularization</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Acute Coronary Syndrome With Renal Dysfunction</condition>
  <arm_group>
    <arm_group_label>suspect acute coronary syndrome</arm_group_label>
    <description>Subjects with the diagnosis of suspected acute coronary syndrome (ACS), age between 20 to 80.&#xD;
Exclusion criteria: pregnant women, patients with end-stage renal disease (eGFR &lt;15 mL/min/1.73 m2), cardiogenic shock.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects between 20-80 yrs, with acute coronary syndrome in NTUH.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - acute coronary syndrome patients&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - cardiogenic shock, pregnancy, end-stage renal disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Chi-Ting Su, MD. MPH, PhD</last_name>
    <phone>+886972652878</phone>
    <email>A01218@ntucc.gov.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yue-Jhu Huang, MS</last_name>
    <phone>+886912282113</phone>
    <email>yuejhuhuang@outlook.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <contact>
      <last_name>Chi-Ting Su, MD, MPH, PhD</last_name>
      <email>A01218@ntucc.gov.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 3, 2021</study_first_submitted>
  <study_first_submitted_qc>August 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2021</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

